Sellas Operating Income from 2010 to 2025

SLS Stock

USD 1.33 0.11 9.02%

Sellas Life Operating Income yearly trend continues to be comparatively stable with very little volatility. Operating Income will likely drop to about -35.8 M in 2025. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Sellas Life Sciences generates from its operations. View All Fundamentals

Operating Income

First Reported

2006-12-31

Previous Quarter

-7.6 M

Current Value

-7.3 M

Quarterly Volatility

3.5 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Sellas Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sellas Life's main balance sheet or income statement drivers, such as Interest Expense of 806.9 K, Other Operating Expenses of 28.8 M or Research Development of 16.3 M, as well as many indicators such as Price To Sales Ratio of 60.05, Dividend Yield of 0.037 or Days Sales Outstanding of 78.69. Sellas financial statements analysis is a perfect complement when working with Sellas Life Valuation or Volatility modules.

Check out the analysis of Sellas Life Correlation against competitors.

Latest Sellas Life's Operating Income Growth Pattern

Below is the plot of the Operating Income of Sellas Life Sciences over the last few years. Operating Income is the amount of profit realized from Sellas Life Sciences operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Sellas Life Sciences is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Sellas Life's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sellas Life's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Sellas Operating Income Regression Statistics

	Arithmetic Mean	(28,917,019)
	Geometric Mean	25,073,290
	Coefficient Of Variation	(40.23)
	Mean Deviation	9,084,017
	Median	(31,089,000)
	Standard Deviation	11,633,909
	Sample Variance	135.3T
	Range	49.8M
	R-Value	(0.38)
	Mean Square Error	124.3T
	R-Squared	0.14
	Significance	0.15
	Slope	(923,236)
	Total Sum of Squares	2030.2T

Sellas Operating Income History

	2025	-35.8 M
	2024	-34.1 M
	2023	-37.9 M
	2022	-42 M
	2021	-25.3 M
	2020	-17 M
	2019	-20 M

Other Fundumenentals of Sellas Life Sciences

Non Operating Income Net Other

Sellas Life Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Total Current Assets	Retained Earnings	Accounts Payable	Short Term Investments	Total Liab	Common Stock	Current Deferred Revenue	Short Term Debt	Net Tangible Assets	Good Will	Long Term Debt Total	Capital Surpluse	Intangible Assets	Property Plant Equipment	Long Term Debt	Deferred Long Term Liab	Net Receivables	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.68	-0.63	0.93	-0.45	-0.23	-0.3	0.86	0.82	0.66	0.46	0.06	0.63	0.63	0.71	0.79	-0.35	0.6	0.47	0.46	-0.05	0.53	-0.13	-0.32
Total Stockholder Equity	0.68		-0.52	0.64	-0.16	-0.33	-0.11	0.22	0.5	0.28	0.34	0.68	0.44	0.1	0.52	0.53	-0.43	0.04	0.21	0.09	-0.07	0.75	0.3	-0.34
Net Debt	-0.63	-0.52		-0.78	0.12	0.32	0.15	-0.47	-0.3	-0.3	0.27	-0.29	-0.3	-0.24	-0.28	-0.2	-0.09	-0.24	-0.23	-0.34	0.35	-0.55	-0.37	0.32
Total Current Assets	0.93	0.64	-0.78		-0.45	-0.27	-0.29	0.8	0.71	0.61	0.36	0.09	0.52	0.6	0.69	0.54	-0.19	0.61	0.49	0.53	0.04	0.59	0.07	-0.37
Retained Earnings	-0.45	-0.16	0.12	-0.45		0.23	0.57	-0.51	-0.69	-0.51	-0.47	-0.11	-0.16	-0.72	-0.87	-0.3	-0.28	-0.74	-0.03	-0.32	-0.61	0.26	0.2	0.03
Accounts Payable	-0.23	-0.33	0.32	-0.27	0.23		-0.37	-0.1	-0.44	-0.21	0.03	-0.42	-0.6	-0.11	-0.46	-0.21	-0.04	-0.18	-0.42	-0.3	0.05	-0.22	-0.02	0.11
Short Term Investments	-0.3	-0.11	0.15	-0.29	0.57	-0.37		-0.33	-0.23	-0.28	-0.23	0.06	0.41	-0.57	-0.33	-0.05	-0.19	-0.49	0.45	0.05	-0.46	0.15	-0.22	-0.1
Total Liab	0.86	0.22	-0.47	0.8	-0.51	-0.1	-0.33		0.75	0.68	0.38	-0.36	0.56	0.79	0.6	0.69	-0.15	0.8	0.48	0.55	-0.01	0.17	-0.39	-0.22
Common Stock	0.82	0.5	-0.3	0.71	-0.69	-0.44	-0.23	0.75		0.67	0.58	0.11	0.73	0.62	0.88	0.71	-0.36	0.67	0.55	0.53	0.22	0.15	-0.43	-0.03
Current Deferred Revenue	0.66	0.28	-0.3	0.61	-0.51	-0.21	-0.28	0.68	0.67		0.24	-0.1	0.35	0.58	0.65	0.56	-0.2	0.8	0.2	0.82	0.15	0.19	-0.14	-0.07
Short Term Debt	0.46	0.34	0.27	0.36	-0.47	0.03	-0.23	0.38	0.58	0.24		-0.1	0.3	0.47	0.62	0.46	-0.42	0.39	0.38	0.05	0.61	0.19	-0.29	-0.15
Net Tangible Assets	0.06	0.68	-0.29	0.09	-0.11	-0.42	0.06	-0.36	0.11	-0.1	-0.1		0.11	-0.3	0.26	0.0	0.02	-0.31	-0.16	-0.16	-0.01	0.3	0.41	-0.16
Good Will	0.63	0.44	-0.3	0.52	-0.16	-0.6	0.41	0.56	0.73	0.35	0.3	0.11		0.16	0.48	0.7	-0.43	0.23	0.83	0.46	-0.3	0.31	-0.54	-0.27
Long Term Debt Total	0.63	0.1	-0.24	0.6	-0.72	-0.11	-0.57	0.79	0.62	0.58	0.47	-0.3	0.16		0.7	0.5	0.14	0.9	0.08	0.26	0.39	-0.01	-0.13	-0.05
Capital Surpluse	0.71	0.52	-0.28	0.69	-0.87	-0.46	-0.33	0.6	0.88	0.65	0.62	0.26	0.48	0.7		0.58	-0.05	0.72	0.31	0.44	0.47	0.15	-0.16	-0.16
Intangible Assets	0.79	0.53	-0.2	0.54	-0.3	-0.21	-0.05	0.69	0.71	0.56	0.46	0.0	0.7	0.5	0.58		-0.44	0.42	0.35	0.26	-0.24	0.31	-0.43	-0.22
Property Plant Equipment	-0.35	-0.43	-0.09	-0.19	-0.28	-0.04	-0.19	-0.15	-0.36	-0.2	-0.42	0.02	-0.43	0.14	-0.05	-0.44		0.11	-0.46	-0.15	0.14	-0.38	0.29	-0.12
Long Term Debt	0.6	0.04	-0.24	0.61	-0.74	-0.18	-0.49	0.8	0.67	0.8	0.39	-0.31	0.23	0.9	0.72	0.42	0.11		0.17	0.61	0.44	-0.04	-0.18	-0.08
Deferred Long Term Liab	0.47	0.21	-0.23	0.49	-0.03	-0.42	0.45	0.48	0.55	0.2	0.38	-0.16	0.83	0.08	0.31	0.35	-0.46	0.17		0.5	-0.1	0.33	-0.48	-0.23
Net Receivables	0.46	0.09	-0.34	0.53	-0.32	-0.3	0.05	0.55	0.53	0.82	0.05	-0.16	0.46	0.26	0.44	0.26	-0.15	0.61	0.5		0.04	0.16	-0.23	-0.14
Short Long Term Debt	-0.05	-0.07	0.35	0.04	-0.61	0.05	-0.46	-0.01	0.22	0.15	0.61	-0.01	-0.3	0.39	0.47	-0.24	0.14	0.44	-0.1	0.04		-0.21	0.09	0.06
Net Invested Capital	0.53	0.75	-0.55	0.59	0.26	-0.22	0.15	0.17	0.15	0.19	0.19	0.3	0.31	-0.01	0.15	0.31	-0.38	-0.04	0.33	0.16	-0.21		0.5	-0.45
Net Working Capital	-0.13	0.3	-0.37	0.07	0.2	-0.02	-0.22	-0.39	-0.43	-0.14	-0.29	0.41	-0.54	-0.13	-0.16	-0.43	0.29	-0.18	-0.48	-0.23	0.09	0.5		-0.11
Capital Stock	-0.32	-0.34	0.32	-0.37	0.03	0.11	-0.1	-0.22	-0.03	-0.07	-0.15	-0.16	-0.27	-0.05	-0.16	-0.22	-0.12	-0.08	-0.23	-0.14	0.06	-0.45	-0.11

Click cells to compare fundamentals

About Sellas Life Financial Statements

Sellas Life shareholders use historical fundamental indicators, such as Operating Income, to determine how well the company is positioned to perform in the future. Although Sellas Life investors may analyze each financial statement separately, they are all interrelated. The changes in Sellas Life's assets and liabilities, for example, are also reflected in the revenues and expenses on on Sellas Life's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Operating Income	-34.1 M	-35.8 M
Non Operating Income Net Other	239.2 K	251.2 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Sellas Stock Analysis

When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sellas Operating Income from 2010 to 2025

Latest Sellas Life's Operating Income Growth Pattern

Sellas Operating Income Regression Statistics

Sellas Operating Income History

Other Fundumenentals of Sellas Life Sciences

Sellas Life Operating Income component correlations

About Sellas Life Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Sellas Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY